Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.

Di Cosimo S, Triulzi T, Pizzamiglio S, De Cecco L, de Azambuja E, Fumagalli D, Putzai L, Harbeck N, Izquierdo M, Peña L, Daidone MG, Huober J, Gori S, Cinieri S, Torri V, Baselga J, Piccart M, de Braud FG, Apolone G, Verderio P, Tagliabue E.

Eur J Cancer. 2019 Sep;118:1-9. doi: 10.1016/j.ejca.2019.06.001. Epub 2019 Jul 5.

2.

Methodological and statistical issues in developing an External Quality Assessment scheme in laboratory medicine: Focus on biomarker research.

Verderio P, Pizzamiglio S, Ciniselli CM.

N Biotechnol. 2019 Sep 25;52:54-59. doi: 10.1016/j.nbt.2019.05.001. Epub 2019 May 3.

PMID:
31059865
3.

Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial.

Di Cosimo S, Appierto V, Pizzamiglio S, Tiberio P, Iorio MV, Hilbers F, de Azambuja E, de la Peña L, Izquierdo M, Huober J, Baselga J, Piccart M, de Braud FG, Apolone G, Verderio P, Daidone MG.

Clin Cancer Res. 2019 Jul 1;25(13):3887-3895. doi: 10.1158/1078-0432.CCR-18-2507. Epub 2019 Feb 27.

PMID:
30814109
4.

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.

Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B, Gelderblom H, Stacchiotti S, Judson I, Dei Tos AP, Verderio P, Casali PG, Woll PJ, Gronchi A; EORTC – Soft Tissue and Bone Sarcoma Group.

Eur J Cancer. 2019 Mar;109:51-60. doi: 10.1016/j.ejca.2018.12.009. Epub 2019 Jan 25.

PMID:
30690293
5.

Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer.

Azzollini J, Pesenti C, Pizzamiglio S, Fontana L, Guarino C, Peissel B, Plebani M, Tabano S, Sirchia SM, Colapietro P, Villa R, Paolini B, Verderio P, Miozzo M, Manoukian S.

Cancers (Basel). 2019 Jan 9;11(1). pii: E58. doi: 10.3390/cancers11010058.

6.

Resting-state functional connectivity predicts the ability to adapt arm reaching in a robot-mediated force field.

Faiman I, Pizzamiglio S, Turner DL.

Neuroimage. 2018 Jul 1;174:494-503. doi: 10.1016/j.neuroimage.2018.03.054. Epub 2018 Mar 26.

PMID:
29588227
7.

Neural predictors of gait stability when walking freely in the real-world.

Pizzamiglio S, Abdalla H, Naeem U, Turner DL.

J Neuroeng Rehabil. 2018 Feb 27;15(1):11. doi: 10.1186/s12984-018-0357-z.

8.

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.

Pasquali S, Colombo C, Pizzamiglio S, Verderio P, Callegaro D, Stacchiotti S, Martin Broto J, Lopez-Pousa A, Ferrari S, Poveda A, De Paoli A, Quagliuolo V, Jurado JC, Comandone A, Grignani G, De Sanctis R, Palassini E, Llomboart-Bosch A, Dei Tos AP, Casali PG, Picci P, Gronchi A.

Eur J Cancer. 2018 Apr;93:28-36. doi: 10.1016/j.ejca.2018.01.071. Epub 2018 Feb 21.

PMID:
29475197
9.

Neural Correlates of Single- and Dual-Task Walking in the Real World.

Pizzamiglio S, Naeem U, Abdalla H, Turner DL.

Front Hum Neurosci. 2017 Sep 14;11:460. doi: 10.3389/fnhum.2017.00460. eCollection 2017.

10.

Muscle co-contraction patterns in robot-mediated force field learning to guide specific muscle group training.

Pizzamiglio S, Desowska A, Shojaii P, Taga M, Turner DL.

NeuroRehabilitation. 2017;41(1):17-29. doi: 10.3233/NRE-171453.

PMID:
28527223
11.

Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.

Spreafico F, Bongarzone I, Pizzamiglio S, Magni R, Taverna E, De Bortoli M, Ciniselli CM, Barzanò E, Biassoni V, Luchini A, Liotta LA, Zhou W, Signore M, Verderio P, Massimino M.

Oncotarget. 2017 Jul 11;8(28):46177-46190. doi: 10.18632/oncotarget.17579.

12.

Neurophysiological Correlates of Featural and Spacing Processing for Face and Non-face Stimuli.

Negrini M, Brkić D, Pizzamiglio S, Premoli I, Rivolta D.

Front Psychol. 2017 Mar 13;8:333. doi: 10.3389/fpsyg.2017.00333. eCollection 2017.

13.

Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.

Fina E, Necchi A, Bottelli S, Reduzzi C, Pizzamiglio S, Iacona C, Daidone MG, Verderio P, Cappelletti V.

Dis Markers. 2017;2017:3414910. doi: 10.1155/2017/3414910. Epub 2017 Feb 22.

14.

Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.

Pizzamiglio S, De Bortoli M, Taverna E, Signore M, Veneroni S, Cho WC, Orlandi R, Verderio P, Bongarzone I.

Int J Mol Sci. 2017 Feb 14;18(2). pii: E410. doi: 10.3390/ijms18020410.

15.

A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs.

Pizzamiglio S, Zanutto S, Ciniselli CM, Belfiore A, Bottelli S, Gariboldi M, Verderio P.

Oncol Lett. 2017 Jan;13(1):315-320. doi: 10.3892/ol.2016.5452. Epub 2016 Nov 30.

16.

High-Frequency Intermuscular Coherence between Arm Muscles during Robot-Mediated Motor Adaptation.

Pizzamiglio S, De Lillo M, Naeem U, Abdalla H, Turner DL.

Front Physiol. 2017 Jan 9;7:668. doi: 10.3389/fphys.2016.00668. eCollection 2016.

17.

The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data.

Korenkova V, Slyskova J, Novosadova V, Pizzamiglio S, Langerova L, Bjorkman J, Vycital O, Liska V, Levy M, Veskrna K, Vodicka P, Vodickova L, Kubista M, Verderio P.

Sci Rep. 2016 Jul 7;6:29023. doi: 10.1038/srep29023.

18.

Developing miRNA signatures: a multivariate prospective.

Verderio P, Bottelli S, Pizzamiglio S, Ciniselli CM.

Br J Cancer. 2016 Jun 28;115(1):1-4. doi: 10.1038/bjc.2016.164. No abstract available.

19.

Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.

Verderio P, Bottelli S, Lecchi M, Plebani M, Gariboldi M, Pizzamiglio S, Ciniselli CM.

Br J Cancer. 2016 May 10;114(10):e5. doi: 10.1038/bjc.2016.1. Epub 2016 Apr 21. No abstract available.

20.

Data and performances evaluation of the SPIDIA-DNA Pan-European External Quality Assessment: 2nd SPIDIA-DNA laboratory report.

Malentacchi F, Pizzamiglio S, Ibrahim-Gawel H, Pazzagli M, Verderio P, Ciniselli CM, Wyrich R, Gelmini S.

Data Brief. 2016 Feb 6;6:980-4. doi: 10.1016/j.dib.2016.01.062. eCollection 2016 Mar.

21.

Effects of Transport and Storage Conditions on Gene Expression in Blood Samples.

Malentacchi F, Pizzamiglio S, Wyrich R, Verderio P, Ciniselli C, Pazzagli M, Gelmini S.

Biopreserv Biobank. 2016 Apr;14(2):122-8. doi: 10.1089/bio.2015.0037. Epub 2016 Feb 17.

PMID:
26886447
22.

Second SPIDIA-DNA External Quality Assessment (EQA): Influence of pre-analytical phase of blood samples on genomic DNA quality.

Malentacchi F, Pizzamiglio S, Ibrahim-Gawel H, Pazzagli M, Verderio P, Ciniselli CM, Wyrich R, Gelmini S.

Clin Chim Acta. 2016 Feb 15;454:10-4. doi: 10.1016/j.cca.2015.12.032. Epub 2015 Dec 23.

PMID:
26721315
23.

Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.

Ciniselli CM, De Bortoli M, Taverna E, Varinelli L, Pizzamiglio S, Veneroni S, Bonini C, Orlandi R, Verderio P, Bongarzone I.

Expert Rev Proteomics. 2015;12(6):695-701. doi: 10.1586/14789450.2015.1099436. Epub 2015 Oct 23.

PMID:
26496240
24.

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M, Marin M, Damiola F, Bernard L, Pensotti V, Volorio S, Dall'Olio V, Meindl A, Bartram C, Sutter C, Surowy H, Sornin V, Dondon MG, Eon-Marchais S, Stoppa-Lyonnet D, Andrieu N, Sinilnikova OM; GENESIS, Mitchell G, James PA, Thompson E; kConFab; SWE-BRCA, Marchetti M, Verzeroli C, Tartari C, Capone GL, Putignano AL, Genuardi M, Medici V, Marchi I, Federico M, Tognazzo S, Matricardi L, Agata S, Dolcetti R, Della Puppa L, Cini G, Gismondi V, Viassolo V, Perfumo C, Mencarelli MA, Baldassarri M, Peissel B, Roversi G, Silvestri V, Rizzolo P, Spina F, Vivanet C, Tibiletti MG, Caligo MA, Gambino G, Tommasi S, Pilato B, Tondini C, Corna C, Bonanni B, Barile M, Osorio A, Benitez J, Balestrino L, Ottini L, Manoukian S, Pierotti MA, Renieri A, Varesco L, Couch FJ, Wang X, Devilee P, Hilbers FS, van Asperen CJ, Viel A, Montagna M, Cortesi L, Diez O, Balmaña J, Hauke J, Schmutzler RK, Papi L, Pujana MA, Lázaro C, Falanga A, Offit K, Vijai J, Campbell I, Burwinkel B, Kvist A, Ehrencrona H, Mazoyer S, Pizzamiglio S, Verderio P, Surralles J, Rogan PK, Radice P.

Hum Mol Genet. 2015 Sep 15;24(18):5345-55. doi: 10.1093/hmg/ddv251. Epub 2015 Jun 30.

25.

Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience.

Malentacchi F, Pizzamiglio S, Verderio P, Pazzagli M, Orlando C, Ciniselli CM, Günther K, Gelmini S.

Clin Chem Lab Med. 2015 Nov;53(12):1935-42. doi: 10.1515/cclm-2014-1161.

PMID:
25883202
26.

Combining qualitative and quantitative imaging evaluation for the assessment of genomic DNA integrity: The SPIDIA experience.

Ciniselli CM, Pizzamiglio S, Malentacchi F, Gelmini S, Pazzagli M, Hartmann CC, Ibrahim-Gawel H, Verderio P.

Anal Biochem. 2015 Jun 15;479:60-2. doi: 10.1016/j.ab.2015.03.023. Epub 2015 Mar 27.

PMID:
25817220
27.

Moving from discovery to validation in circulating microRNA research.

Verderio P, Bottelli S, Ciniselli CM, Pierotti MA, Zanutto S, Gariboldi M, Pizzamiglio S.

Int J Biol Markers. 2015 May 26;30(2):e258-61. doi: 10.5301/jbm.5000135.

PMID:
25704507
28.

Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Cortelazzi B, Verderio P, Ciniselli CM, Pizzamiglio S, Bossi P, Gloghini A, Gualeni AV, Volpi CC, Locati L, Pierotti MA, Licitra L, Pilotti S, Perrone F.

J Oral Pathol Med. 2015 Oct;44(9):734-45. doi: 10.1111/jop.12301. Epub 2014 Dec 14.

PMID:
25495427
29.

Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experience.

Malentacchi F, Ciniselli CM, Pazzagli M, Verderio P, Barraud L, Hartmann CC, Pizzamiglio S, Weisbuch S, Wyrich R, Gelmini S.

Clin Chim Acta. 2015 Feb 2;440:205-10. doi: 10.1016/j.cca.2014.12.004. Epub 2014 Dec 6.

PMID:
25485853
30.

SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses.

Malentacchi F, Pazzagli M, Simi L, Orlando C, Wyrich R, Günther K, Verderio P, Pizzamiglio S, Ciniselli CM, Zhang H, Korenková V, Rainen L, Bar T, Kubista M, Gelmini S.

PLoS One. 2014 Nov 10;9(11):e112293. doi: 10.1371/journal.pone.0112293. eCollection 2014.

31.

Biomarkers for monitoring pre-analytical quality variation of mRNA in blood samples.

Zhang H, Korenková V, Sjöback R, Švec D, Björkman J, Kruhøffer M, Verderio P, Pizzamiglio S, Ciniselli CM, Wyrich R, Oelmueller U, Kubista M, Lindahl T, Lönneborg A, Rian E.

PLoS One. 2014 Nov 4;9(11):e111644. doi: 10.1371/journal.pone.0111644. eCollection 2014.

32.

Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.

Gündisch S, Slotta-Huspenina J, Verderio P, Ciniselli CM, Pizzamiglio S, Schott C, Drecoll E, Viertler C, Zatloukal K, Kap M, Riegman P, Esposito I, Specht K, Babaryka G, Asslaber M, Bodó K, den Bakker M, den Hollander J, Fend F, Neumann J, Reu S, Perren A, Langer R, Lugli A, Becker I, Richter T, Kayser G, May AM, Carneiro F, Lopes JM, Sobin L, Höfler H, Becker KF.

Virchows Arch. 2014 Nov;465(5):509-19. doi: 10.1007/s00428-014-1624-4. Epub 2014 Aug 2.

PMID:
25085759
33.

NqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data.

Verderio P, Bottelli S, Ciniselli CM, Pierotti MA, Gariboldi M, Pizzamiglio S.

Anal Biochem. 2014 Sep 15;461:7-9. doi: 10.1016/j.ab.2014.05.020. Epub 2014 Jun 2.

PMID:
24892985
34.

Circulating free DNA in a screening program for early colorectal cancer detection.

Perrone F, Lampis A, Bertan C, Verderio P, Ciniselli CM, Pizzamiglio S, Frattini M, Nucifora M, Molinari F, Gallino G, Gariboldi M, Meroni E, Leo E, Pierotti MA, Pilotti S.

Tumori. 2014 Mar-Apr;100(2):115-21. doi: 10.1700/1491.16389.

PMID:
24852853
35.

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo.

Catucci I, Peterlongo P, Ciceri S, Colombo M, Pasquini G, Barile M, Bonanni B, Verderio P, Pizzamiglio S, Foglia C, Falanga A, Marchetti M, Galastri L, Bianchi T, Corna C, Ravagnani F, Bernard L, Fortuzzi S, Sardella D, Scuvera G, Peissel B, Manoukian S, Tondini C, Radice P.

Genet Med. 2014 Sep;16(9):688-94. doi: 10.1038/gim.2014.13. Epub 2014 Feb 20.

PMID:
24556926
36.

Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study.

Pardini B, Verderio P, Pizzamiglio S, Nici C, Maiorana MV, Naccarati A, Vodickova L, Vymetalkova V, Veneroni S, Daidone MG, Ravagnani F, Bianchi T, Bujanda L, Carracedo A, Castells A, Ruiz-Ponte C, Morreau H, Howarth K, Jones A, Castellví-Bel S, Li L, Tomlinson I, Van Wezel T, Vodicka P, Radice P, Peterlongo P; EPICOLON Consortium.

PLoS One. 2014 Jan 21;9(1):e85538. doi: 10.1371/journal.pone.0085538. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e91310.

37.

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer.

Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, Perrone F, Leo E, Pilotti S, Verderio P, Gariboldi M, Pierotti MA.

Br J Cancer. 2014 Feb 18;110(4):1001-7. doi: 10.1038/bjc.2013.819. Epub 2014 Jan 14.

38.

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, Bongarzone I.

Ann Oncol. 2014 Feb;25(2):352-7. doi: 10.1093/annonc/mdt490. Epub 2013 Dec 3.

PMID:
24306042
39.

A normalization strategy for the analysis of plasma microRNA qPCR data in colorectal cancer.

Pizzamiglio S, Bottelli S, Ciniselli CM, Zanutto S, Bertan C, Gariboldi M, Pierotti MA, Verderio P.

Int J Cancer. 2014 Apr 15;134(8):2016-8. doi: 10.1002/ijc.28530. Epub 2013 Oct 22. No abstract available.

40.

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale.

Terrenato I, Arena V, Pizzamiglio S, Pennacchia I, Perracchio L, Buglioni S, Ercolani C, Sperati F, Costarelli L, Bonanno E, Baldini D, Candia S, Crescenzi A, Dal Mas A, Di Cristofano C, Gomes V, Grillo LR, Pasquini P, Pericoli MN, Ramieri MT, Di Stefano D, Ruco L, Scarpino S, Vitolo D, d'Amati G, Paradiso A, Verderio P, Mottolese M.

J Exp Clin Cancer Res. 2013 Aug 21;32:58. doi: 10.1186/1756-9966-32-58.

41.

SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses.

Malentacchi F, Pazzagli M, Simi L, Orlando C, Wyrich R, Hartmann CC, Verderio P, Pizzamiglio S, Ciniselli CM, Tichopad A, Kubista M, Gelmini S.

Clin Chim Acta. 2013 Sep 23;424:274-86. doi: 10.1016/j.cca.2013.05.012. Epub 2013 May 25.

PMID:
23714327
42.

Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa.

Musella V, Verderio P, Reid JF, Pizzamiglio S, Gariboldi M, Callari M, Milione M, De Cecco L, Veneroni S, Pierotti MA, Daidone MG.

PLoS One. 2013;8(1):e53406. doi: 10.1371/journal.pone.0053406. Epub 2013 Jan 7. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/11071e0f-4f09-4b1f-93ec-f1362610ce33. Massimo, Milione [corrected to Milione, Massimo].

43.

X chromosome inactivation pattern in BRCA gene mutation carriers.

Manoukian S, Verderio P, Tabano S, Colapietro P, Pizzamiglio S, Grati FR, Calvello M, Peissel B, Burn J, Pensotti V, Allemani C, Sirchia SM, Radice P, Miozzo M.

Eur J Cancer. 2013 Mar;49(5):1136-41. doi: 10.1016/j.ejca.2012.10.013. Epub 2012 Nov 9.

PMID:
23146957
44.

Comment to "Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's disease".

Verderio P, Ciniselli CM, Pizzamiglio S.

Dig Liver Dis. 2013 Mar;45(3):265. doi: 10.1016/j.dld.2012.09.015. Epub 2012 Nov 7. No abstract available.

PMID:
23141870
45.

SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses.

Pazzagli M, Malentacchi F, Simi L, Orlando C, Wyrich R, Günther K, Hartmann CC, Verderio P, Pizzamiglio S, Ciniselli CM, Tichopad A, Kubista M, Gelmini S.

Methods. 2013 Jan;59(1):20-31. doi: 10.1016/j.ymeth.2012.10.007. Epub 2012 Oct 27.

PMID:
23110812
46.

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.

Gronchi A, Verderio P, De Paoli A, Ferraro A, Tendero O, Majò J, Martin J, Comandone A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Palassini E, Stacchiotti S, Ferrari S, Fiore M, Casali PG.

Ann Oncol. 2013 Mar;24(3):817-23. doi: 10.1093/annonc/mds501. Epub 2012 Oct 30.

PMID:
23110811
47.

Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.

Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B; kConFab, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P.

Hum Mutat. 2012 Dec;33(12):1665-75. doi: 10.1002/humu.22159. Epub 2012 Aug 2.

PMID:
22753153
48.

Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy.

Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, Martin J, Comandone A, Cruz J, Ferraro A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Casali PG, Gronchi A.

Cancer. 2012 Dec 1;118(23):5857-66. doi: 10.1002/cncr.27624. Epub 2012 May 17.

49.

The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians.

Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall'olio V, Sardella D, Ravagnani F, Galastri L, Barile M, Peissel B, Zaffaroni D, Manoukian S, Radice P, Peterlongo P.

Breast Cancer Res Treat. 2012 Jun;133(2):805-7. doi: 10.1007/s10549-012-2011-y. Epub 2012 Mar 14. No abstract available.

PMID:
22415478
50.

Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse.

Perotti D, Spreafico F, Torri F, Gamba B, D'Adamo P, Pizzamiglio S, Terenziani M, Catania S, Collini P, Nantron M, Pession A, Bianchi M, Indolfi P, D'Angelo P, Fossati-Bellani F, Verderio P, Macciardi F, Radice P; Associazione Italiana Ematologia Oncologia Pediatrica Wilms Tumor Working Group.

Genes Chromosomes Cancer. 2012 Jul;51(7):644-53. doi: 10.1002/gcc.21951. Epub 2012 Mar 8.

PMID:
22407497

Supplemental Content

Loading ...
Support Center